Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

A 58-year-old man has a hemoglobin of 20.5 g/dL, hematocrit of 62%, and splenomegaly. Serum erythropoietin level is low, arterial oxygen saturation is normal, and JAK2 V617F mutation testing is positive. Platelet count is 550,000/uL. Which complication is he most likely to develop if untreated?

  • A Recurrent gram-negative sepsis
  • B Arterial and venous thrombosis
  • C Immune-mediated hemolytic anemia
  • D Progressive cerebellar ataxia
Correct answer: B. Arterial and venous thrombosis

Explanation

Polycythemia vera, defined here by elevated hematocrit, low erythropoietin, and JAK2 V617F mutation, carries a major risk of thrombosis due to hyperviscosity and platelet activation, affecting both cerebral and portal venous systems; Budd-Chiari syndrome is a classic manifestation. Treatment with phlebotomy and aspirin targets exactly this risk. Sepsis, immune hemolysis, and ataxia are not recognized complications of untreated polycythemia vera.

Reference: Robbins and Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →